Altered Blood–Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis

Altered Blood–Brain Barrier Dynamics in the C9orf72 Hexanucleotide Repeat Expansion Mouse Model of Amyotrophic Lateral Sclerosis

For peripherally administered drugs to reach the central nervous system (CNS) and treat amyotrophic lateral sclerosis (ALS), they must cross the blood–brain barrier (BBB). As mounting evidence suggests that the ultrastructure of the BBB is altered in individuals with ALS and in animal models of ALS...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Yijun Pan, Yoshiteru Kagawa, Jiaqi Sun, Bradley J. Turner, Cheng Huang, Anup D. Shah, Ralf B. Schittenhelm, Joseph A. Nicolazzo
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: MDPI AG 2022-12-01
Cyfres:Pharmaceutics
Pynciau:
amyotrophic lateral sclerosis
blood–brain barrier
brain microvascular endothelial cells
C9orf72 gene
proteomics
Mynediad Ar-lein:https://www.mdpi.com/1999-4923/14/12/2803

Rhyngrwyd

https://www.mdpi.com/1999-4923/14/12/2803

Eitemau Tebyg